Jul 222020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, UT – Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, today announced the election of Dr. Daniel Skovronsky to its Board of Directors, effective immediately, expanding the Board to ten members. Additionally, Dr. Skovronsky was appointed to the Research and Product Innovation ...

Myriad Genetics adds Dr Daniel Skovronsky to its Board of Directors

Myriad Genetics adds Dr Daniel Skovronsky to its Board of Directors

From:: Myriad Genetics adds Dr Daniel Skovronsky to its Board of Directors

Sorry, the comment form is closed at this time.